Table 1 Patient characteristics.

From: Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML

N (%)

FAMYLY

LAM 2001 D

All

30 (100)

75 (100)

Median age (min–max)

54 (30–64)

49 (19–60)

Male sex

18 (60)

46 (61)

WBC > 30 109/L

3 (10)

NR

PS 0–1

26 (87)

64 (85)

Extramedullary disease

1 (3)

NR

Secondary AML

2 (7)

0 (0)

Cytogenetics*

 Complex (≥ 3 abnormalities)

17 (57)

41 (55)

 Monosomal

12 (40)

32 (43)

 − 17

10 (33)

15 (20)

 7q/− 7

8 (27)

30 (40)

 11q23 abnormality

8 (27)

17 (23)

 3q26 abnormality

7 (23)

7 (9)

 5q/− 5

6 (20)

28 (37)

 t(6;9)

1 (3)

2 (3)

  1. NR not reported, PS performance status, WBC white blood count.
  2. *The sum exceeds the total because of the presence of multiple abnormalities.
Back to article page